NZ592228A - Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field - Google Patents
Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical fieldInfo
- Publication number
- NZ592228A NZ592228A NZ592228A NZ59222806A NZ592228A NZ 592228 A NZ592228 A NZ 592228A NZ 592228 A NZ592228 A NZ 592228A NZ 59222806 A NZ59222806 A NZ 59222806A NZ 592228 A NZ592228 A NZ 592228A
- Authority
- NZ
- New Zealand
- Prior art keywords
- receptors
- compounds
- medical field
- ppar
- egf
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- 102000001301 EGF receptor Human genes 0.000 title 1
- 108060006698 EGF receptor Proteins 0.000 title 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000389A ITRM20050389A1 (it) | 2005-07-22 | 2005-07-22 | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| NZ566045A NZ566045A (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ592228A true NZ592228A (en) | 2012-10-26 |
Family
ID=37579831
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ592228A NZ592228A (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| NZ566045A NZ566045A (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ566045A NZ566045A (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
Country Status (23)
| Country | Link |
|---|---|
| US (6) | US8153841B2 (enExample) |
| EP (1) | EP1910270B3 (enExample) |
| JP (1) | JP5312026B2 (enExample) |
| KR (1) | KR101317519B1 (enExample) |
| CN (2) | CN102020577B (enExample) |
| AU (1) | AU2006271165C1 (enExample) |
| CA (1) | CA2616146C (enExample) |
| CY (1) | CY1114294T1 (enExample) |
| DK (1) | DK1910270T6 (enExample) |
| EA (2) | EA014665B3 (enExample) |
| ES (1) | ES2421260T7 (enExample) |
| HR (1) | HRP20130549T4 (enExample) |
| IL (2) | IL188878A (enExample) |
| IT (1) | ITRM20050389A1 (enExample) |
| MX (1) | MX366596B (enExample) |
| NO (1) | NO340680B1 (enExample) |
| NZ (2) | NZ592228A (enExample) |
| PL (1) | PL1910270T6 (enExample) |
| PT (1) | PT1910270E (enExample) |
| SI (1) | SI1910270T1 (enExample) |
| UA (1) | UA100359C2 (enExample) |
| WO (1) | WO2007010516A2 (enExample) |
| ZA (2) | ZA200801671B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050390A1 (it) * | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| IE20070129A1 (en) * | 2007-02-28 | 2008-12-24 | Giuliani Int Ltd | Ppar-gamma agonists stimulate enteric defensin expression |
| ITMI20072429A1 (it) | 2007-12-24 | 2009-06-25 | Giuliani Int Ltd | Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca |
| UA107562C2 (uk) * | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| PT2805746T (pt) * | 2009-02-16 | 2020-08-17 | Nogra Pharma Ltd | Compostos de alquilamido e utilizações dos mesmos |
| CN102906074A (zh) | 2010-05-24 | 2013-01-30 | 东亚荣养株式会社 | 稠合咪唑衍生物 |
| CN116602950A (zh) * | 2012-02-09 | 2023-08-18 | 诺格拉制药有限公司 | 治疗纤维化的方法 |
| KR20150002819A (ko) | 2012-04-18 | 2015-01-07 | 노그라 파마 리미티드 | 락토스 불내증의 치료 방법 |
| FR2996545B1 (fr) | 2012-10-08 | 2016-03-25 | Ecole Polytech | Procede microfluidique de traitement et d'analyse d'une solution contenant un materiel biologique, et circuit microfluidique correspondant. |
| JP6496302B2 (ja) * | 2014-03-20 | 2019-04-03 | 京セラ株式会社 | ユーザ端末、通信制御方法及び基地局 |
| WO2017093444A1 (en) * | 2015-12-01 | 2017-06-08 | Nogra Pharma Limited | Compositions for oral administration in the treatment of inflammatory bowel disease |
| US20220000818A1 (en) | 2019-01-25 | 2022-01-06 | Nogra Pharma Limited | Compositions for use in preventing acne |
| RS66513B1 (sr) * | 2019-02-08 | 2025-03-31 | Nogra Pharma Ltd | Postupak pripreme 3-(4'-aminofenil)-2-metoksipropionske kiseli-ne i njenih analoga i intermedijera |
| WO2025132838A1 (en) | 2023-12-20 | 2025-06-26 | Nogra Pharma Limited | Acne topical formulations |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB767788A (en) | 1953-12-28 | 1957-02-06 | Schering Corp | Polyiodinated phenyl fatty acid compounds and process for their manufacture |
| US3211610A (en) * | 1961-09-29 | 1965-10-12 | Merck & Co Inc | Benzoic acid ester derivatives for treating coccidiosis and method of using same |
| US3444232A (en) * | 1966-05-18 | 1969-05-13 | Squibb & Sons Inc | O-alkyl or phenylalkyl benzohydroxamic acids |
| GB1359560A (en) | 1972-02-25 | 1974-07-10 | Merck & Co Inc | Preparation of pyrrylsalicylic acid |
| US4036951A (en) * | 1973-03-12 | 1977-07-19 | Synergistics, Inc. | Ultra-violet filtration with certain aminosalicylic acid esters |
| FR2440353A1 (fr) * | 1978-11-03 | 1980-05-30 | Science Union & Cie | Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament |
| US4348223A (en) * | 1980-12-05 | 1982-09-07 | Ppg Industries, Inc. | N-Alkyl-N-[3-(alkoxyalkyl)phenyl]-2-haloacetamide herbicides |
| EP0055689B1 (de) * | 1980-12-22 | 1984-07-04 | Schering Aktiengesellschaft | In 3-Stellung substituierte 2,4,6-trihalogenierte Benzamide und deren Salze, deren Herstellung und Verwendung als Ersatzstoffe für natürliche Süssstoffe sowie Süssungsmittel auf Basis dieser Verbindungen |
| JPS58194814A (ja) | 1982-05-11 | 1983-11-12 | Nippon Shinyaku Co Ltd | 免疫調節作用を有する薬剤 |
| IL69282A (en) | 1982-09-02 | 1988-06-30 | Euro Celtique Sa | Method for the carboxylation of potassium phenoxide with carbon dioxide |
| DE3786452T2 (de) * | 1987-02-05 | 1993-10-21 | Kureha Chemical Ind Co Ltd | Benzylether-Verbindungen und Verfahren zu ihrer Herstellung. |
| AU1388388A (en) | 1987-04-01 | 1988-10-06 | Dak-Laboratoriet A/S | Benzoic acid derivatives and use thereof |
| ATE113209T1 (de) | 1988-05-05 | 1994-11-15 | Tillotts Pharma Ag | Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten. |
| US5519014A (en) * | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| ES2213139T5 (es) | 1990-10-22 | 2011-03-18 | Centre For Digestive Diseases Pty Ltd | Tratamiento de trastornos intestinales no inflamatorios. |
| US5262549A (en) * | 1991-05-30 | 1993-11-16 | Polaroid Corporation | Benzpyrylium dyes, and processes for their preparation and use |
| US5302751A (en) | 1992-01-21 | 1994-04-12 | Ethyl Corporation | Profen resolution |
| CA2120367C (en) | 1992-06-30 | 2004-05-11 | Howard K. Shapiro | Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology |
| US5594151A (en) * | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| EP0759750A4 (en) | 1994-05-11 | 1998-05-27 | Howard K Shapiro | PREPARATIONS FOR TREATING CHRONIC FLAMMABLE DISEASES |
| US5594015A (en) | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
| HUP9900309A3 (en) | 1995-03-28 | 1999-11-29 | Janssen Pharmaceutica Nv | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases |
| US5939442A (en) * | 1995-06-07 | 1999-08-17 | The Salk Institute For Biological Studies | Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9617001D0 (en) | 1996-08-13 | 1996-09-25 | Tillotts Pharma Ag | Oral composition |
| DE19647582A1 (de) * | 1996-11-18 | 1998-05-20 | Hoechst Ag | Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane |
| AU6773598A (en) | 1997-03-26 | 1998-10-20 | Institut Pasteur | Treatment of gastrointestinal disease with ppar modulators |
| WO1999005161A1 (en) * | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
| AU9002798A (en) * | 1997-09-19 | 1999-04-12 | Ono Pharmaceutical Co. Ltd. | Fused or nonfused benzene compounds |
| FR2773075B1 (fr) | 1997-12-31 | 2000-05-05 | Cird Galderma | Utilisation d'activateurs de ppar-gamma en dermatologie |
| US6114382A (en) | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
| US6326364B1 (en) * | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| FR2791671B1 (fr) | 1999-04-01 | 2001-05-11 | Oreal | Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation |
| GB9908647D0 (en) | 1999-04-15 | 1999-06-09 | Smithkline Beecham Plc | Novel compounds |
| US20040034067A1 (en) * | 1999-04-15 | 2004-02-19 | Macphee Colin Houston | Novel method of treatment |
| GB9914371D0 (en) | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| JP3854154B2 (ja) | 2000-04-19 | 2006-12-06 | ニューロテック カンパニー リミテッド | 中枢神経系の急性及び慢性的損傷に起因した神経変性を防止するための化合物、組成物及び方法 |
| SI1285908T1 (sl) * | 2000-05-29 | 2008-12-31 | Kyorin Seiyaku Kk | Substituirani fenilpropionski kislinski derivati |
| US7049342B2 (en) | 2000-05-29 | 2006-05-23 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropionic acid derivatives |
| ES2333337T3 (es) * | 2000-08-29 | 2010-02-19 | Biocon Limited | Uso de una composicion farmaceutica que contiene un derivado de acido para-aminofenilacetico para tratar afecciones inflamatorias del tracto gastrointestinal. |
| CA2430846A1 (en) | 2000-12-05 | 2002-06-13 | Kyorin Pharmaceutical Co., Ltd. | Substituted carboxylic acid derivatives |
| FR2822955B1 (fr) | 2001-03-27 | 2003-10-03 | Chru Lille | Methode de diagnostic de maladies inflammatoires chroniques de l'intestin |
| CA2443935A1 (en) | 2001-04-18 | 2002-10-31 | Merck & Co., Inc. | Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| CA2354921A1 (en) | 2001-05-24 | 2002-11-24 | Yasuo Konishi | Drug evolution: drug design at hot spots |
| PL369732A1 (en) * | 2001-10-16 | 2005-05-02 | Dr.Reddy's Laboratories Ltd. | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| UA82835C2 (en) | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
| US20030113815A1 (en) * | 2001-12-19 | 2003-06-19 | Pfizer Inc. | Canine peroxisome proliferator activated receptor gamma |
| US20030220374A1 (en) * | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
| US20040115127A1 (en) * | 2002-04-12 | 2004-06-17 | Wright Samuel D. | Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| GB0303609D0 (en) | 2003-02-17 | 2003-03-19 | Glaxo Group Ltd | Novel therapeutic method and compositions |
| US20060159648A1 (en) | 2003-02-17 | 2006-07-20 | Davis Adrian F | Novel therapeutic method and compositions for topical administration |
| EP1607103A1 (en) | 2003-03-20 | 2005-12-21 | Eisai Co., Ltd. | Concomitant drug as therapeutic agent for inflammatory bowel disease |
| US7589232B2 (en) | 2003-07-21 | 2009-09-15 | Laboratories Serono S.A. | Alkynyl aryl carboxamides |
| JP2007509180A (ja) | 2003-10-21 | 2007-04-12 | インスパイアー ファーマシューティカルズ，インコーポレイティド | 疼痛を治療するための、非ヌクレオチド組成物および方法 |
| EP1680397A2 (en) * | 2003-10-28 | 2006-07-19 | Dr. Reddy's Laboratories Ltd. | Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| US20070086967A1 (en) | 2003-12-03 | 2007-04-19 | Brian Macdonald | Treatment of psoriasis with rosiglitazone |
| CA2553775A1 (en) | 2004-01-20 | 2005-08-11 | Richard F. Harty | Compositions and methods of treatment for inflammatory diseases |
| WO2005084658A1 (en) | 2004-03-04 | 2005-09-15 | Arakis Ltd. | Derivatives of actarit and their therapeutic use |
| US20060286046A1 (en) | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
| US20060270635A1 (en) * | 2005-05-27 | 2006-11-30 | Wallace John L | Derivatives of 4- or 5-aminosalicylic acid |
| ITRM20050389A1 (it) * | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| DE102005061472A1 (de) * | 2005-12-22 | 2007-07-05 | Saltigo Gmbh | Verfahren zur Herstellung von enantiomerenangereicherten 2-Alkoxy-3-phenylpropionsäuren |
| WO2007096148A1 (en) | 2006-02-23 | 2007-08-30 | Lipid Nutrition B.V. | Immunoregulation |
| US7645801B2 (en) | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
| IE20070129A1 (en) | 2007-02-28 | 2008-12-24 | Giuliani Int Ltd | Ppar-gamma agonists stimulate enteric defensin expression |
| WO2009025854A1 (en) | 2007-08-22 | 2009-02-26 | Burnham Institute For Medical Research | Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| ITMI20072429A1 (it) | 2007-12-24 | 2009-06-25 | Giuliani Int Ltd | Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca |
| US8030520B2 (en) | 2008-03-31 | 2011-10-04 | Saltigo Gmbh | Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| PT2805746T (pt) | 2009-02-16 | 2020-08-17 | Nogra Pharma Ltd | Compostos de alquilamido e utilizações dos mesmos |
| EP2298321A1 (en) | 2009-08-26 | 2011-03-23 | Nordic Pharma | Novel pharmaceutical compositions for treating IBD |
| CA2841358A1 (en) | 2011-07-15 | 2013-01-24 | S.L.A. Pharma Ag | Pharmaceutical compositions for rectal administration |
| EP2773378B1 (en) | 2011-10-31 | 2016-08-10 | Larsen, Claus Selch | Prodrugs of non-steroid anti-inflammatory agents (nsaids) |
| CN116602950A (zh) * | 2012-02-09 | 2023-08-18 | 诺格拉制药有限公司 | 治疗纤维化的方法 |
| KR20150002819A (ko) | 2012-04-18 | 2015-01-07 | 노그라 파마 리미티드 | 락토스 불내증의 치료 방법 |
| CN104619687A (zh) | 2012-06-01 | 2015-05-13 | 诺格拉制药有限公司 | 能够调节t-细胞应答的双环杂环及其使用方法 |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| HRP20181000T1 (hr) | 2012-09-13 | 2018-09-21 | Nogra Pharma Limited | Postupci liječenja stanja povezanih s kosom |
| MX2015003279A (es) | 2012-09-13 | 2015-07-06 | Nogra Pharma Ltd | Metodos para inhibir el crecimiento de vello corporal. |
| US20180193361A1 (en) | 2015-04-02 | 2018-07-12 | University Health Network | Gut anti-inflammatory agents for regulation of high blood glucose levels |
| CA2986611C (en) | 2015-06-15 | 2023-10-03 | Nmd Pharma Aps | Compounds for use in treating neuromuscular disorders |
-
2005
- 2005-07-22 IT IT000389A patent/ITRM20050389A1/it unknown
-
2006
- 2006-07-24 MX MX2013012753A patent/MX366596B/es unknown
- 2006-07-24 ES ES06766085.2T patent/ES2421260T7/es active Active
- 2006-07-24 NZ NZ592228A patent/NZ592228A/xx unknown
- 2006-07-24 SI SI200631598T patent/SI1910270T1/sl unknown
- 2006-07-24 CN CN2010105208008A patent/CN102020577B/zh active Active
- 2006-07-24 PT PT67660852T patent/PT1910270E/pt unknown
- 2006-07-24 HR HRP20130549TT patent/HRP20130549T4/hr unknown
- 2006-07-24 EP EP06766085.2A patent/EP1910270B3/en active Active
- 2006-07-24 DK DK06766085.2T patent/DK1910270T6/en active
- 2006-07-24 CN CN2006800300777A patent/CN101243039B/zh active Active
- 2006-07-24 JP JP2008522170A patent/JP5312026B2/ja active Active
- 2006-07-24 KR KR1020087003953A patent/KR101317519B1/ko active Active
- 2006-07-24 EA EA200800372A patent/EA014665B3/ru active IP Right Maintenance
- 2006-07-24 PL PL06766085T patent/PL1910270T6/pl unknown
- 2006-07-24 CA CA2616146A patent/CA2616146C/en active Active
- 2006-07-24 NZ NZ566045A patent/NZ566045A/en unknown
- 2006-07-24 WO PCT/IE2006/000078 patent/WO2007010516A2/en not_active Ceased
- 2006-07-24 AU AU2006271165A patent/AU2006271165C1/en active Active
- 2006-07-24 EA EA201000708A patent/EA017566B1/ru not_active IP Right Cessation
- 2006-07-24 UA UAA200802141A patent/UA100359C2/uk unknown
- 2006-07-24 US US11/989,090 patent/US8153841B2/en active Active
-
2008
- 2008-01-17 IL IL188878A patent/IL188878A/en active IP Right Review Request
- 2008-01-18 NO NO20080325A patent/NO340680B1/no unknown
- 2008-02-20 ZA ZA2008/01671A patent/ZA200801671B/en unknown
-
2010
- 2010-05-26 IL IL205992A patent/IL205992A/en active IP Right Grant
- 2010-11-18 ZA ZA2010/08268A patent/ZA201008268B/en unknown
-
2012
- 2012-02-29 US US13/408,439 patent/US8710100B2/en active Active
-
2013
- 2013-07-05 CY CY20131100562T patent/CY1114294T1/el unknown
-
2014
- 2014-03-10 US US14/202,386 patent/US9133099B2/en active Active
-
2015
- 2015-03-27 US US14/671,579 patent/US9561202B2/en active Active
- 2015-03-27 US US14/671,585 patent/US9345680B2/en active Active
-
2016
- 2016-12-13 US US15/377,013 patent/US10016381B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ592228A (en) | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field | |
| MX2007010404A (es) | Hidrazinometilo, hidrazonometilo y compuestos heterociclicos de 5 miembros que actuan como inhibidores de mtor y su uso como agentes anti-cancer. | |
| WO2009047298A3 (en) | Dimers of harmol or of its derivatives and uses thereof | |
| TW357148B (en) | Heterocycle-condensed morphinoid derivatives (II) the invention relates to a substituted mono heterocycle-condensed morphinoid derivatives as analgesics and for treating pathological conditions | |
| CY1111310T1 (el) | Ενωσεις για την αγωγη μεταβολικων διαταραχων | |
| ATE530066T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| TW200728914A (en) | A salt suitable for an acid generator and a chemically amplified resist composition containing the same | |
| GEP20125523B (en) | Metabolites of (thio) carbamoyl-cyclohexane derivatives | |
| PH12015501098A1 (en) | Antituberculous composition comprising oxazole compounds | |
| IN2014DN06850A (enExample) | ||
| MY148988A (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
| TW200728915A (en) | A salt suitable for an acid generator and a chemically amplified resist composition containing the same | |
| TW200744659A (en) | Preparation for preventing and ameliorating wrinkle | |
| DE602006005227D1 (de) | Len und tropolon | |
| MY150783A (en) | Aqueous cleaning composition for substrate for perpendicular magnetic recording hard disk | |
| ZA200807946B (en) | Skin lightening agents, compositions and methods | |
| IN2009CN02681A (enExample) | ||
| WO2008078445A1 (ja) | 重合性化合物及び重合性組成物 | |
| MX2010002822A (es) | Composicion herbicida. | |
| MX2010002761A (es) | Tratamiento de cerdos para reducir la relacion de conversion de alimento o incrementar la velocidad de crecimiento. | |
| TW200722433A (en) | Phosphorus compounds, use thereof and flame retarding polyester fibers | |
| UA102539C2 (ru) | Производные оксадиазола, активные в отношении сфингозин-1-фосфата (s1p) | |
| WO2007010514A3 (en) | Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field | |
| TW200745269A (en) | Novel compound, optical filter using the compound, and optical recording material | |
| WO2007010294A3 (en) | Use of delmopinol in the treatment of acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 24 JUL 2013 BY TOMKINS + CO Effective date: 20130514 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 24 JUL 2016 BY TOMKINS + CO Effective date: 20130711 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2017 BY COMPUTER PACKAGES INC Effective date: 20160701 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2018 BY COMPUTER PACKAGES INC Effective date: 20170701 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2019 BY COMPUTER PACKAGES INC Effective date: 20180703 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2020 BY COMPUTER PACKAGES INC Effective date: 20190702 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2021 BY COMPUTER PACKAGES INC Effective date: 20200701 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2022 BY COMPUTER PACKAGES INC Effective date: 20210630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2023 BY COMPUTER PACKAGES INC Effective date: 20220630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2024 BY COMPUTER PACKAGES INC Effective date: 20230630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 24 JUL 2025 BY COMPUTER PACKAGES INC Effective date: 20240630 |